Unknown

Dataset Information

0

CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols.


ABSTRACT: Purpose: Noninvasive and quantitative tracking of CD8+ T cells by PET has emerged as a potential technique to gauge response to immunotherapy. We apply an anti-CD8 cys-diabody, labeled with 64Cu, to assess the sensitivity of PET imaging of normal and diseased tissue.Experimental Design: Radiolabeling of an anti-CD8 cys-diabody (169cDb) with 64Cu was developed. The accumulation of 64Cu-169cDb was evaluated with PET/CT imaging (0, 5, and 24 hours) and biodistribution (24 hours) in wild-type mouse strains (n = 8/group studied with imaging and IHC or flow cytometry) after intravenous administration. Tumor-infiltrating CD8+ T cells in tumor-bearing mice treated with CpG and ?PD-1 were quantified and mapped (n = 6-8/group studied with imaging and IHC or flow cytometry).Results: We demonstrate the ability of immunoPET to detect small differences in CD8+ T-cell distribution between mouse strains and across lymphoid tissues, including the intestinal tract of normal mice. In FVB mice bearing a syngeneic HER2-driven model of mammary adenocarcinoma (NDL), 64Cu-169cDb PET imaging accurately visualized and quantified changes in tumor-infiltrating CD8+ T cells in response to immunotherapy. A reduction in the circulation time of the imaging probe followed the development of treatment-related liver and splenic hypertrophy and provided an indication of off-target effects associated with immunotherapy protocols.Conclusions: 64Cu-169cDb imaging can spatially map the distribution of CD8+ T cells in normal organs and tumors. ImmunoPET imaging of tumor-infiltrating cytotoxic CD8+ T cells detected changes in T-cell density resulting from adjuvant and checkpoint immunotherapy protocols in our preclinical evaluation. Clin Cancer Res; 24(20); 4976-87. ©2018 AACR.

SUBMITTER: Seo JW 

PROVIDER: S-EPMC6215696 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD8<sup>+</sup> T-Cell Density Imaging with <sup>64</sup>Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols.

Seo Jai Woong JW   Tavaré Richard R   Mahakian Lisa M LM   Silvestrini Matthew T MT   Tam Sarah S   Ingham Elizabeth S ES   Salazar Felix B FB   Borowsky Alexander D AD   Wu Anna M AM   Ferrara Katherine W KW  

Clinical cancer research : an official journal of the American Association for Cancer Research 20180702 20


<b>Purpose:</b> Noninvasive and quantitative tracking of CD8<sup>+</sup> T cells by PET has emerged as a potential technique to gauge response to immunotherapy. We apply an anti-CD8 cys-diabody, labeled with <sup>64</sup>Cu, to assess the sensitivity of PET imaging of normal and diseased tissue.<b>Experimental Design:</b> Radiolabeling of an anti-CD8 cys-diabody (169cDb) with <sup>64</sup>Cu was developed. The accumulation of <sup>64</sup>Cu-169cDb was evaluated with PET/CT imaging (0, 5, and 24  ...[more]

Similar Datasets

| S-EPMC8319402 | biostudies-literature
| S-EPMC7178340 | biostudies-literature
| S-EPMC6081756 | biostudies-literature
| S-EPMC8026513 | biostudies-literature
| S-EPMC6682141 | biostudies-literature
| S-EPMC6170330 | biostudies-literature
| S-EPMC6482841 | biostudies-literature
| S-EPMC6580847 | biostudies-literature
| S-EPMC6923301 | biostudies-literature
| S-EPMC7668034 | biostudies-literature